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Summary We evaluated the effect of low-frequency repetitive transcranial mag-
netic stimulation (rTMS) on seizure frequency in adult patients with medically
intractable extratemporal lobe epilepsy (ETLE). Seven patients with medically
intractable ETLE received low-frequency rTMS at 0.9 Hz, basically two sets of
15 min stimulation per day for five days in a week, with the stimulus intensity of
90% of resting motor threshold (RMT). The number of seizures during two weeks
before and after the stimulation of one week was compared. Furthermore, RMT and
active motor threshold (AMT) were measured before and after rTMS for each daily
session. After low-frequency rTMS of one week, the frequency of all seizure types,
complex partial seizures (CPSs) and simple partial seizures was reduced by 19.1, 35.9
and 7.4%, respectively. The patients with smaller difference between RMT and AMT
before rTMS had higher reduction rate of CPSs. A favorable tendency of seizure
reduction, though not statistically significant, during two weeks after low-frequency
rTMS was demonstrated in medically intractable ETLE patients. As far as CPSs are
concerned, smaller decrease of motor threshold by voluntary muscle contraction was
associated with better response to rTMS.
# 2005 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.Introduction
Transcranial magnetic stimulation (TMS) has
become an important diagnostic tool for evaluating
the degree of cortical excitability in human brain.* Corresponding author. Tel.: +81 75 751 3772;
fax: +81 75 751 9416.
E-mail address: akio@kuhp.kyoto-u.ac.jp (A. Ikeda).
1 Present address: Takeda General Hospital, Kyoto, Japan.
1059-1311/$ — see front matter # 2005 BEA Trading Ltd. Published
doi:10.1016/j.seizure.2005.05.002Repetitive TMS (rTMS) can be used to modulate
cortical excitability, and several therapeutic trials
have demonstrated its clinical efficacy in movement
disorders such as Parkinson’s disease1 and writer’s
cramp.2 In the field of clinical epileptology, several
studies have suggested therapeutic use of rTMS and
electric cortical stimulation for seizure control.3—8
Despite a potential risk to activate epileptic focus
by TMS,9 the safety of low-frequency rTMS has
already been established,10,11 and reduction ofby Elsevier Ltd. All rights reserved.
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suggested.3—5 rTMS could have a similar mechanism
of action to that of electric cortical stimulation for
seizure suppression, and recently we demonstrated
that electric cortical stimulation at 0.9 Hz as well as
50 Hz has suppressive effect on epileptic spikes.6—8
A previous open study showed significant seizure
reduction by 0.33 Hz rTMS in seven patients with
extratemporal lobe epilepsy (ETLE) and two with
temporal lobe epilepsy (TLE).3 A case report showed
70% seizure reduction by 0.5 Hz low-frequency rTMS
in a patient with intractable partial seizures due to
focal cortical dysplasia in the parietal region.4 A
recent controlled study, by using 1 Hz rTMS for
15 min twice daily for one week at 120% of motor
threshold (MT), showed a trend of short-term sei-
zure decrease mainly in patients with neocortical
rather than mesial temporal foci.5 However, neither
adequate parameter for stimulation nor factors for
predicting the efficacy of this method have been
fully established.
We aimed at accumulating data of seizure reduc-
tion by low-frequency rTMS in adult patients with
ETLE, based on the hypothesis that patients with
neocortical epilepsy may show better therapeutic
outcome than those with TLE because of the proxi-
mity of the epileptic focus to the TMS coil in the
former rather than in the latter. We also measured
MT by single pulse TMS, trying to evaluate whether
cortical excitability at the baseline level relate to
the degree of seizure reduction.Methods
Subjects
Seven patients, two male and five female (age
23.3  5.4, mean  S.D.) seen in epilepsy clinic inTable 1 Demographics of patients.
Number Age Seizure class Seizure type Focusa
1 21F FLE SPSs, CPSs F4
2 22F Special
syndrome
SPSs, CPSs P3
3 27F FLE SPSs, CPSs F3
4 33M FLE SPSs, CPSs F4
5 21F FLE SPSs F3
6 23F FLE CPSs, GTC Ss F3
7 16M PLE CPSs, GTC Ss P3
FLE: frontal lobe epilepsy; PLE: parietal lobe epilepsy; CPSs: co
generalized tonic—clonic seizures; CBZ: carbamazepine; VPA: valp
CLB: clobazam; CZP: clonazepam; PRM: primidone; DZP: diazepam
a Electrode position with most active epileptogenicity during videthe Department of Neurology, Kyoto University Hos-
pital, were studied. Demographics of the patients
are shown in Table 1. All the patients fulfilled the
following conditions: (1) partial seizures originating
from the cortical areas other than mesial temporal
lobe, (2) occurrence of two or more seizures per
week for the recent six months in spite of the
maximum tolerable dose of various combinations
of oral antiepileptic medications, (3) steady state
medication maintained at least for one month
before starting this study, and (4) epilepsy surgery
not indicated by comprehensive work-up such as
long-term video EEG monitoring and neuroimaging
studies. All patients gave written informed consent
after full explanation about the procedures and
possible side effects, according to the research
protocol (No. 235) approved by the Ethical Commit-
tee of Kyoto University Graduate School of Medi-
cine.
Repetitive transcranial magnetic
stimulation (rTMS)
Low-frequency rTMS was delivered by a round coil
with an intermediate diameter of 9 cm using a
device of Magstim Super Rapid Magnetic Stimulator
(Magstim Co., Whitland, Dyfed, UK). The center of
the coil was placed at either FCz or PCz, and the
electric current in the coil was either clockwise or
counterclockwise, depending on the target region
where the most prominent epileptic activity was
documented by the long-term video EEG monitoring
(Table 1). The intensity of rTMS was set to 90% of the
resting motor threshold (RMT) or 100% of active
motor threshold (AMT) when RMT was higher than
the maximum output of the stimulator. Basically, we
delivered rTMS with the frequency of 0.9 Hz for
15 min, which is known to depress cortical excit-
ability,12 twice daily with the intermission for 5 min,Medication Other condition
CBZ, VPA
CBZ, AZA Hypothalamic hamartoma
CBZ, PHT, NZP, CLB Bilateral frontal subcortical
band heterotopia
CZP, CBZ, PRM, DZP Positive history of viral
encephalitis
CBZ, CLB
CBZ, PHT, CLB, ZNS
PHT, PB, PRM Focal cortical dysplasia
mplex partial seizures; SPSs: simple partial seizures; GTCSs:
roate; AZA: acetazolamide; PHT: phenytoin; NZP: nitrazepam;
; ZNS: zonisamide; PB: phenobarbital.
o EEG monitoring.
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Figure 1 Changes of seizure frequency after low-fre-
quency rTMS for each individual patient. Filled squares
and error bars shown on the side of each data are the
mean  S.E. of seizure frequency. (a) All seizure types, (b)
CPSs and (c) SPSs.and it was repeated for five days in a week. This
procedure was partly similar to that adopted in the
previous report.5 When the patient complained of
unendurable symptoms such as focal headache and
muscle contraction under the coil, the stimulus
intensity was reduced to 90% of AMT, and if that
intensity was still intolerable, the stimulation was
stopped for several minutes, and re-started after
full recovery if the patient agreed. For patients 1
and 2, the 15 min session was delivered once
daily.
In case convulsive seizures occurred during rTMS,
we planned to judge whether they were evoked by
TMS or not based on the presence of elicited jerking
of the target muscle and spreading to the proximal
parts.13
Study of motor cortex excitability change
RMTand AMTwere determined using the same round
coil as used for low-frequency rTMS before and after
stimulation on each day. Motor-evoked potential
(MEP) was recorded by a pair of surface electrodes
from the first dorsal interosseous muscle (FDI) con-
tralateral to the hemisphere in which the most
frequent seizure activities were observed by video
EEGmonitoring. The threshold intensity for MEP was
expressed as a percentage of the maximum stimu-
lator output. RMTwas defined as the lowest intensity
to elicit an MEP of more than 50 mV in three out of
five consecutive trials by increasing the stimulus
intensity from subthreshold levels by 1%. AMT was
defined as the lowest intensity to elicit an MEP of
more than 200 mV in three out of five consecutive
trials during the maximum voluntary tonic contrac-
tion of FDI. Averaged MT per patient over five days in
the week of stimulation was used for comparison
between before and after stimulation for every day.
To evaluate the effect of five-day rTMS, MT values
before stimulation on the first day were compared
to that on the fifth day across patients. When the MT
exceeded the maximum intensity of the stimulator,
it was arbitrarily regarded as 100% for statistical
analyses.
Seizure frequency evaluation
All patients and their families documented every
seizure for two weeks each before and after the
week of low-frequency rTMS. Every seizure was
classified into seizure types14 (SPSs, CPSs and gen-
eralized tonic—clonic seizures (GTC Ss)) based on
the clinical observation, and the mean number of
seizures per week was calculated for each seizure
type. During the study period, medication was kept
constant.Statistics
For comparison between seizure frequency and MT,
nonparametric methods (Wilcoxon’s signed rank
test and Mann—Whitney U-test) were used. Ken-
dall’s tests were employed for correlation analyses
comparing the degree of seizure decrease with the
mean MT across five days, which was measured
before rTMS for every day for each patient. Signifi-
cance level was set to p < 0.05.Results
Effect of rTMS on seizures
Before low-frequency rTMS, the mean seizure fre-
quency per week of all seizure types, CPSs and SPSs
was 16.5  5.2, 7.7  1.9 and 13.6  5.5 (mean
 S.E.), respectively. After low-frequency rTMS,
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Figure 2 Scatter plot showing the relationship between
the reduction of MT by voluntary muscle contraction
(RMT—AMT, percent stimulator output) and percent
decrease of CPSs after low-frequency rTMS. Smaller
decrease of motor threshold by voluntary muscle contrac-
tion is associated with larger reduction of CPSs.the mean seizure frequency across the patients for
all seizure types, CPSs and SPSs was 13.4  4.4,
4.9  1.4 and 12.6  5.1 (Fig. 1), and reduction rate
was 19.1%, 35.9% and 7.4%, respectively. The degree
of seizure reduction did not reach statistical signifi-
cance. By comparison of seizure frequency before
and after rTMS, there was a tendency that rTMS was
more effective for CPSs than SPSs. Four patients
(patients 1—4) reported subjective improvement of
seizures not only in frequency but also in duration
and severity. Patient 4, who mainly had CPSs before
stimulation, almost exclusively had SPSs after rTMS,
and thus this patient showed the maximum reduc-
tion of CPSs by 88.5%. Patient 2 had very unpleasant
aura almost continuously before rTMS, which
was markedly reduced after rTMS. Two patients
(patients 5 and 6) who had seizures only during sleep
period showed no reduction of seizures by low-
frequency rTMS.
Patient 6 had three GTC Ss during the two weeks
of observation period before rTMS, and had two GTC
Ss after rTMS. During rTMS, two patients (patients 2
and 6) complained of headache in the region
attached to the TMS coil. No convulsive seizure
was induced by TMS in this study. Patient 3 had SPSs
and CPSs of the same semiology and severity as her
habitual ones during stimulation, which was consid-
ered not to be evoked by rTMS. Stimulation was
continued during the habitual SPSs, but stopped
during CPSs, and re-started after full recovery if
the patient agreed.
Effect of rTMS on MT
The patients showed relatively high RMT and AMT
before rTMS (Table 2). In patient 2, MT was not
measured on the fifth day after rTMS because of
headache, and thus the averaged data of the other
four days was used. MT data of patient 6 were not
included for the comparison between before andTable 2 Motor threshold.
Each day of
stimulationa
Five days of
stimulationb
Before After First day Fifth day
RMT 82.1  7.2 82.5  7.3 86.7  6.9 81.0  7.6
AMT 68.1  6.4 66.2  5.4 72.5  6.3 67.3  7.5
Mean  S.E. Data from patient 6 was not included because the
value was not reliable (see text). RMT, resting motor thresh-
old; AMT, active motor threshold.
a Values measured before and after rTMS on each day of
stimulation from during the first week of stimulation.
b Values measured before rTMS on the first and fifth day of
stimulation.after rTMS, because the MTof the ipsilateral FDI was
adopted as the stimulus intensity of everyday sti-
mulation, since MT of the left FDI was lower than
that of the right by TMS over left hemisphere.
Neither RMT nor AMT changed after low-frequency
rTMS within each day, and there was no significant
change in RMTor AMTafter five days of rTMS, either
(Table 2). For any type of seizures (all seizure types,
SPSs and CPSs), reduction rate was not significantly
correlated with RMT or AMT. However, difference
between AMT and RMT was significantly correlated
with the reduction rate of CPSs (Kendall’s test,
p < 0.05, t = 0.733) (Fig. 2), showing that smaller
decrease of MT by voluntary muscle contraction was
associated with larger reduction of CPSs. In this
correlation analysis we used MT data of patient 6
obtained by the figure-of-eight coil placed on the
left hemisphere.
Discussion
This pilot study showed a favorable tendency of
seizure reduction in two weeks after low-frequency
rTMS in medically intractable ETLE patients. The
frequency of all seizure types, CPSs and SPSs
reduced by 19.1, 35.9 and 7.4%, respectively. The
degree of decrease in all seizure types was similar to
that reported in the previous controlled study,
which showed 16% reduction in all patients and
24% reduction in neocortical epilepsy patients dur-
ing two weeks of post-rTMS period.5 It is probably
due to the similar stimulation parameter of 1 Hz for
15 min twice daily employed in that study.5 Other
studies with better seizure outcome employed
stimulating frequency of 0.33 Hz3 and 0.5 Hz,4
and thus slower stimulus rate than ours would be
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longer period. This hypothesis conflicts with the
previous study that showed greater amplitude
reduction of MEP by rTMS at 0.9 Hz than 0.1 Hz,12
but supports their description that the spread of
excitation and changes of MEP amplitude are possi-
bly independent phenomena.12 However, data
obtained from healthy subjects cannot be directly
adopted, since patients had seizure and were trea-
ted by antiepileptic drugs that canmodify the effect
of low-frequency rTMS.
It is noteworthy, although not statistically signif-
icant, that the overall mean reduction of CPSs
frequency across the patients was 35.9% in the
present study, and the maximum reduction rate of
CPSs per patient was 88.5%. A relatively high effec-
tiveness of low-frequency rTMS to CPSs than to SPSs
contradicts the common notion that SPSs is a milder
or more fragmented seizure than CPSs. One possible
explanation for this phenomenon is that low-fre-
quency rTMS is sufficiently effective enough to sup-
press the seizure spread, but is not so sufficient as to
suppress epileptic activities at the seizure foci. The
suppression of seizure spread may be related to the
enhancement of surround inhibition, as demon-
strated by a prolonged inhibitory synaptic potential
at the cellular level.15
The present study showed relatively high MT in
epilepsy patients, all of whom were treated by
sodium channel blockers (carbamazepine and/or
phenytoin) known to increase MT.16,17 Because of
the small patient population of this study, we could
not further evaluate the effect of each antiepileptic
drug on MT or on the clinical efficacy of low-fre-
quency rTMS. The present study did not show any
changes in RMTor AMT by low-frequency rTMS, when
compared between before and after stimulation of
either each day or across five days, possibly because
motor cortex was not directly stimulated. However,
considering previous reports in which inhibition of
ipsilateral motor cortex after subthreshold low-fre-
quency rTMS on premotor cortex were demon-
strated by reduction of MEP size,18 task-related
EEG power and EEG—EMG coherence,19 the present
observation may suggest that low-frequency rTMS
have little effect upon the neuronal membrane
excitability.16 The present study also showed that
the difference between AMT and RMT correlated
significantly to the reduction rate of CPSs, that is,
the smaller the difference between RMT and AMT,
themore effective was rTMS. The reduction of MT by
voluntary tonic contraction is related to increased
excitability of corticospinal neurons20 and spinal
motoneurons,21 and basically RMT and AMT behave
similarly as demonstrated in the pharmacological
challenge in healthy subjects.16 Patients with largerreduction of MT by voluntary muscle contraction
may still have significant capacity to increase excit-
ability in this motor system despite antiepileptic
medication, which may result in insufficient seizure
reduction by low-frequency rTMS. We used the max-
imum voluntary muscle contraction to determine
AMT because fine control of the degree of muscle
strength was difficult for patients, while usually 20%
of the maximum muscle force is used to define AMT.
The condition of AMT in the present study may have
led to a greater difference between AMT and RMT,
enabling us to demonstrate significant correlation.
Other parameters indicating intracortical inhibition
by means of paired pulse stimulation may demon-
strate further information.
In summary, this was the first pilot study to test
the therapeutic effect of rTMS in a patient group
consisting exclusively of ETLE and to evaluate the
relationship between the therapeutic outcome of
rTMS and cortical excitability as shown by RMTand
AMT. A favorable tendency of seizure reduction
was shown, though not statistically significant,
in two weeks after low-frequency rTMS in medi-
cally intractable ETLE patients, especially those of
CPSs, possibly through a suppressive effect on
seizure spread. For the practical use of low-fre-
quency rTMS for seizure reduction, larger studies
are needed to investigate better stimulation para-
meters, prognostic factors and interaction with
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